To determine whether butyric acid mitigates PCOS phenotypes through the gut–brain axis, we assessed the levels of brain–gut regulators peptide tyrosine-tyrosine (PYY) and G protein-coupled receptor 41 (GPR41) in rats. This evidence concerns the gene FFAR3 and polycystic ovary syndrome.